Literature DB >> 24140285

Are we missing opportunities to confirm the diagnosis of tuberculosis by microbial culture?

Zaid Al-Nakeeb1, Vandana Gupta, Christine Bell, Mark Woodhead.   

Abstract

SETTING: Tuberculosis (TB) incidence is rising globally, with drug resistance becoming increasingly problematic. Microbiological confirmation ensures correct anti-tuberculous chemotherapy. OBJECTIVE/
DESIGN: We retrospectively analysed all TB cases diagnosed in Central Manchester in 2009 investigating how often we are not achieving microbiological diagnosis, factors influencing this and whether opportunities to obtain microbiological samples are missed.
RESULTS: 128/156 (82%) cases had samples sent for microbiology. Factors affecting this included disease site, with ocular disease least likely to be sampled (p < 0.0001), and patient age (with children less likely to be sampled p = 0.002). Ethnicity did not affect sampling (n.s.). Overall, 92/156 (59%) cases were culture positive. Negative culture was related to specimen type (p < 0.0001) and patient age (p = 0.019), with children significantly less likely to have a positive culture. Ethnicity and disease site did not affect culture results. There was a trend towards culture positivity being more common in pulmonary (75%) than non-pulmonary (46%) disease (n.s.). In only 7 (4%), could samples have been sent where they were originally absent (3) or further samples obtained where the cultures proved to be negative (4).
CONCLUSION: Despite an overall culture positive rate of 59%, opportunities to achieve microbiological confirmation are seldom missed. In our centre, which is typical of UK practice, this lack of capacity to increase microbiological confirmation, particularly in an era of increasing importance of extra-pulmonary TB, is concerning. Improvements in sample acquisition and laboratory methods are urgently required.
Copyright © 2013 Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  Investigation; Microbiological diagnosis; Mycobacteria

Mesh:

Year:  2013        PMID: 24140285     DOI: 10.1016/j.rmed.2013.09.016

Source DB:  PubMed          Journal:  Respir Med        ISSN: 0954-6111            Impact factor:   3.415


  5 in total

1.  Ocular Tuberculosis--A Clinical Conundrum.

Authors:  Cecilia Lee; Rupesh Agrawal; Carlos Pavesio
Journal:  Ocul Immunol Inflamm       Date:  2015-06-25       Impact factor: 3.070

2.  The problem with defining foreign birth as a risk factor in tuberculosis epidemiology studies.

Authors:  Jennifer L Guthrie; Lisa A Ronald; Victoria J Cook; James Johnston; Jennifer L Gardy
Journal:  PLoS One       Date:  2019-04-30       Impact factor: 3.240

3.  Cancer obscures extrapulmonary tuberculosis (EPTB) at a tertiary hospital in Northern Malawi.

Authors:  M R O Chisale; F Sinyiza; P Kaseka; J S T Wu; C Chimbatata; B C Mbakaya; P S Kamudumuli; A B Kayira
Journal:  Epidemiol Infect       Date:  2020-10-20       Impact factor: 2.451

4.  Changes in chest X-ray findings in 1- and 2-month group after treatment initiation for suspected pulmonary tuberculosis.

Authors:  Jang Ho Lee; Ock-Hwa Kim; Yeon Joo Kim; Tae Sun Shim; Kyung-Wook Jo
Journal:  Korean J Intern Med       Date:  2020-02-18       Impact factor: 2.884

5.  Metagenomic Next-Generation Sequencing versus Traditional Pathogen Detection in the Diagnosis of Peripheral Pulmonary Infectious Lesions.

Authors:  Jie Huang; Erlie Jiang; Donglin Yang; Jialin Wei; Mingfeng Zhao; Jing Feng; Jie Cao
Journal:  Infect Drug Resist       Date:  2020-02-19       Impact factor: 4.003

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.